Erythema gyratum repens-like eruption after anti-IL-17 therapy of pityriasis rubra pilaris
- 1 January 2021
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (1), E38-E40
- https://doi.org/10.1111/jdv.16785
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra PilarisJAMA Dermatology, 2020
- Pityriasis rubra pilaris as a systemic diseaseClinics in Dermatology, 2019
- Transformation from pityriasis rubra pilaris to erythema gyratum repens–like eruption without associated malignancy: A report of 2 casesJAAD Case Reports, 2018
- Pityriasis rubra pilaris: algorithms for diagnosis and treatmentJournal of the European Academy of Dermatology and Venereology, 2018
- Interleukin 23–Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra PilarisJAMA Dermatology, 2017
- Pityriasis rubra pilaris treated with methotrexate resolving with an erythema gyratum repens–like appearanceJournal of the American Academy of Dermatology, 2013
- Erythema gyratum repens, not always a bad omen for patientsJournal of the European Academy of Dermatology and Venereology, 2010
- Erythema Gyratum RepensThe American Journal of the Medical Sciences, 2001
- Erythema gyratum repens: A paraneoplastic eruptionJournal of the American Academy of Dermatology, 1992
- Erythema gyratum repens, a stage in the resolution of pityriasis rubra pilaris?Clinical and Experimental Dermatology, 1985